0910-AF38 201410 The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS Over-the-Counter (OTC) Drug Review--Laxative Drug Products Other Significant Previously Published in The Unified Agenda Final Rule Stage No No 21 CFR 201 21 CFR 310 21 CFR 330 to 358 21 USC 321p 21 USC 331 21 USC 351 to 353 21 USC 355 21 USC 360 to 360a 21 USC 371 to 371a No Final Action (Granular Psyllium) 03/29/2007 72 FR 14669 NPRM (Professional Labeling--Sodium Phosphate) 02/11/2011 76 FR 7743 NPRM Comment Period End 03/14/2011 Final Action (Professional Labeling--Sodium Phosphate) 10/00/2015 Yes Businesses Local State Yes Yes No 0910-AA01 Split from Janice Adams-King 0910 Food and Drug Administration FDA 301 796-3713 301 796-9899 janice.adams-king@fda.hhs.gov Center for Drug Evaluation and Research, WO 22, Room 5416, 10903 New Hampshire Avenue, Silver Spring MD 20993